CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 687-690

  Rudd, Christopher E ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

CD8+ T cells; Co stimulatory molecules; Cytotoxicity

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANZYME B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN;

AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOTOXICITY; EFFECTOR CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MOUSE MUTANT;

ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 64049090936     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939261     Document Type: Note

References (29)

1. Greenwald, R. J., Freeman, G. J. and Sharpe, A. H., The B7 family revisited. Annu. Rev. Immunol. 2005. 23: 515-548.
2. Rudd, C. E. and Schneider, H., Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 2003. 3: 544-556.
3. Chikuma, S. and Bluestone, J. A., CTLA-4 and tolerance: The biochemical point of view. Immunol. Res. 2003. 28: 241-253.
4. Grakoui, A., Wherry, J. E., Hanson, H. L., Walker, C. and Ahmed R., Turning on the off switch: Regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway. J. Hepatol. 2006. 45: 468-472.
5. Krummel, M. F. and Allison, J. P., CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 1995. 182: 459-465.
6. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
7. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
8. Waterhouse, P., Penninger, J. M., Timms, E.,Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B. et al., Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995. 270: 985-988.
9. Rudd, C. E., The reverse stop-signal model for CTLA4 function. Nat. Rev. Immunol. 2008. 8: 153-160.
10. Schneider, H., Smith, X., Liu, H., Bismuth, G. and Rudd, C., CTLA-4 expression disrupts ZAP-70 microcluster formation, T-cell/APC conjugation and calcium mobilization. Eur. J. Immunol. 2007. 38: 40-47.
11. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P. et al., CTLA-4-Ig regulates tryptophan catabolism in vivo.. Nat. Immunol. 2002. 3: 1056-1057.
12. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T. and Sakaguchi, S., CTLA-4 control over Foxp31 regulatory T cell function. Science. 2008. 322: 271-275.
13. Schmidt, E. M., Wang, C. J., Ryan, G. A., Clough, L. E., Qureshi, Q. S., Goodall, M., Abbas, A. K. et al., CTLA-4 controls regulatory T cell peripheral homeostasis and is required for the suppression of pancreatic islet autoimmunity. J. Immunol. 2009. 182: 274-282.
14. Schneider, H., Valk, E., Leung, R. and Rudd, C. E., CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. PLoS ONE 2008. 3: E3842.
15. Schneider, H., Downey, J., Smith, A., Zinselmeyer, B. H., Rush, C., Brewer, J. M., Wei, B. et al., Reversal of the TCR stop signal by CTLA-4. Science 2006. 313: 1972-1975.
16. + T cell homeostasis. J. Immunol. 2008. 181: 1806-1813.
17. + regulatory T cells abrogates their function in vivo. J. Immunol. 2006. 177: 4376-43783.
18. + regulatory T cell function. Eur. J. Immunol. 2004. 34: 2996-3005.
19. + T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
20. Fearon, D. T., The expansion and maintenance of antigen-selected CD8(+) T cell clones. Adv. Immunol. 2007. 96: 103-139.
21. Pandiyan, P., Hegel, J. K., Frueger, M., Quandt, D. and Brunner-Weinzierl, M. C., High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4). J. Immunol. 2007. 178: 2132-2140.
22. Leach, D. R., Krummel, M. F. and Allison, J. P., Enhancement of anti-tumor immunity by CTLA-4 blockade. Science 1996. 271: 1734-1736.
23. + T-lymphocytes by repressing Eomesodermin. Eur. J. Immunol. 2009. 39: 883-893.
24. + T cell function by the transcription factor Eomesodermin. Science 2003. 302: 1041-1043.
25. Glimcher, L. H., Townsend, M. J., Sullican, B. M. and Lord, G. M., Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 2004. 4: 900-911.
26. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005. 6: 1236-1244.
27. Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P. and Glimcher, L. H., Distinct effects of T-bet in TH1 lineage commitment and IFNgamma production in CD4 and CD8 T-cells. Science 2002. 295: 338-342.
28. + T cell differentiation. J. Immunol. 2006. 177: 7515-7519.
29. Suto, A., Wurster, A. L., Reiner, S. L. and Grusby, M. J., IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 2006. 177: 3721-3727.